Keith Q. Tanis

1.5k total citations
34 papers, 947 citations indexed

About

Keith Q. Tanis is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Keith Q. Tanis has authored 34 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Pharmacology and 5 papers in Oncology. Recurrent topics in Keith Q. Tanis's work include Pharmacogenetics and Drug Metabolism (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Alzheimer's disease research and treatments (4 papers). Keith Q. Tanis is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Alzheimer's disease research and treatments (4 papers). Keith Q. Tanis collaborates with scholars based in United States, France and Slovakia. Keith Q. Tanis's co-authors include Ronald S. Duman, Samuel S. Newton, Alexei A. Podtelezhnikov, Anthony J. Koleske, David J. Stone, Henry S. Duewel, Darren R. Veach, William G. Bornmann, John J. Renger and Frank D. Sistare and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Keith Q. Tanis

33 papers receiving 935 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith Q. Tanis United States 18 350 186 163 117 116 34 947
Anbarasu Lourdusamy United Kingdom 21 619 1.8× 276 1.5× 304 1.9× 38 0.3× 84 0.7× 59 1.3k
Peter Keane United Kingdom 17 417 1.2× 247 1.3× 361 2.2× 149 1.3× 124 1.1× 32 1.2k
Liza Barki‐Harrington Israel 19 1.0k 2.9× 101 0.5× 498 3.1× 42 0.4× 58 0.5× 38 1.5k
Yokesh Balaraman United States 9 429 1.2× 123 0.7× 111 0.7× 42 0.4× 34 0.3× 11 790
Jöelle Hillion United States 24 1.5k 4.2× 80 0.4× 929 5.7× 77 0.7× 80 0.7× 31 2.2k
Heike Rebholz United States 18 1.2k 3.4× 199 1.1× 203 1.2× 35 0.3× 50 0.4× 27 1.6k
Marcin Piechota Poland 22 550 1.6× 185 1.0× 445 2.7× 49 0.4× 83 0.7× 61 1.4k
Anna Kinsey United Kingdom 12 353 1.0× 376 2.0× 293 1.8× 52 0.4× 57 0.5× 15 831
Juan M. Luque Spain 22 557 1.6× 228 1.2× 727 4.5× 58 0.5× 90 0.8× 41 1.6k
Chiara Villa Italy 23 948 2.7× 508 2.7× 258 1.6× 29 0.2× 83 0.7× 76 1.9k

Countries citing papers authored by Keith Q. Tanis

Since Specialization
Citations

This map shows the geographic impact of Keith Q. Tanis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Q. Tanis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Q. Tanis more than expected).

Fields of papers citing papers by Keith Q. Tanis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Q. Tanis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Q. Tanis. The network helps show where Keith Q. Tanis may publish in the future.

Co-authorship network of co-authors of Keith Q. Tanis

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Q. Tanis. A scholar is included among the top collaborators of Keith Q. Tanis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Q. Tanis. Keith Q. Tanis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hafey, Michael J., Robert Houle, Keith Q. Tanis, et al.. (2020). A Two-Tiered In Vitro Approach to De-Risk Drug Candidates for Potential Bile Salt Export Pump Inhibition Liabilities in Drug Discovery. Drug Metabolism and Disposition. 48(11). 1147–1160. 14 indexed citations
2.
El‐Bizri, Nesrine, Jing Liu, Rachel A. Matt, et al.. (2020). Abstract 13402: FHL-1 Contributes to and Colocalizes With Titin in Cardiac Hypertrophy. Circulation. 142(Suppl_3). 1 indexed citations
3.
Tanis, Keith Q., Alexei A. Podtelezhnikov, Truyen Nguyen, et al.. (2020). Application of a Rat Liver Drug Bioactivation Transcriptional Response Assay Early in Drug Development That Informs Chemically Reactive Metabolite Formation and Potential for Drug-induced Liver Injury. Toxicological Sciences. 177(1). 281–299. 22 indexed citations
4.
Podtelezhnikov, Alexei A., Amy G. Aslamkhan, Kara Pearson, et al.. (2020). Quantitative Transcriptional Biomarkers of Xenobiotic Receptor Activation in Rat Liver for the Early Assessment of Drug Safety Liabilities. Toxicological Sciences. 175(1). 98–112. 28 indexed citations
5.
Li, Yutai, Raymond Evers, Michael J. Hafey, et al.. (2019). Use of a Bile Salt Export Pump Knockdown Rat Susceptibility Model to Interrogate Mechanism of Drug-Induced Liver Toxicity. Toxicological Sciences. 170(1). 180–198. 7 indexed citations
6.
Stopa, Edward G., Keith Q. Tanis, Miles C. Miller, et al.. (2018). Comparative transcriptomics of choroid plexus in Alzheimer’s disease, frontotemporal dementia and Huntington’s disease: implications for CSF homeostasis. Fluids and Barriers of the CNS. 15(1). 18–18. 80 indexed citations
7.
Rothman, Sarah M., Keith Q. Tanis, Pallavi Gandhi, et al.. (2018). Human Alzheimer’s disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology. Journal of Neuroinflammation. 15(1). 256–256. 30 indexed citations
8.
Lebrón, José Antonio, Keith Q. Tanis, Lei Zhu, et al.. (2017). Use of Alternative Developmental Toxicity Assays to Assess Teratogenicity Potential of Pharmaceuticals. 4(1). 44–53. 6 indexed citations
9.
Cazanave, Sophie C., Alexei A. Podtelezhnikov, Mulugeta Seneshaw, et al.. (2017). The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease. Scientific Reports. 7(1). 17193–17193. 50 indexed citations
10.
Nikonova, Elena, Keith Q. Tanis, Alexei A. Podtelezhnikov, et al.. (2017). Transcriptional Profiling of Cholinergic Neurons From Basal Forebrain Identifies Changes in Expression of Genes Between Sleep and Wake. SLEEP. 40(6). 11 indexed citations
11.
Qin, Chunhua, Keith Q. Tanis, Alexei A. Podtelezhnikov, et al.. (2016). Toxicogenomics in drug development: a match made in heaven?. Expert Opinion on Drug Metabolism & Toxicology. 12(8). 847–849. 11 indexed citations
12.
Podtelezhnikov, Alexei A., Keith Q. Tanis, Michael Nebozhyn, et al.. (2011). Molecular Insights into the Pathogenesis of Alzheimer's Disease and Its Relationship to Normal Aging. PLoS ONE. 6(12). e29610–e29610. 58 indexed citations
13.
Voleti, Bhavya, Keith Q. Tanis, Samuel S. Newton, & Ronald S. Duman. (2011). Analysis of Target Genes Regulated by Chronic Electroconvulsive Therapy Reveals Role for Fzd6 in Depression. Biological Psychiatry. 71(1). 51–58. 22 indexed citations
14.
McCampbell, Alexander, Michael W. Marlatt, Dawn Toolan, et al.. (2010). Induction of Alzheimer’s-like changes in brain of mice expressing mutant APP fed excess methionine. Journal of Neurochemistry. 116(1). 82–92. 19 indexed citations
15.
Miller, Miles C., Edward G. Stopa, Elena Nikonova, et al.. (2010). Alterations in choroid plexus gene expression in Alzheimer’s disease provide inferences for CSF composition and dynamics. SHILAP Revista de lepidopterología. 7(S1). 4 indexed citations
16.
Winrow, Christopher J., Keith Q. Tanis, Alison Rigby, et al.. (2009). Refined anatomical isolation of functional sleep circuits exhibits distinctive regional and circadian gene transcriptional profiles. Brain Research. 1271. 1–17. 13 indexed citations
17.
Cao, Xiaoqing, Keith Q. Tanis, Anthony J. Koleske, & John Colicelli. (2008). Enhancement of ABL Kinase Catalytic Efficiency by a Direct Binding Regulator Is Independent of Other Regulatory Mechanisms. Journal of Biological Chemistry. 283(46). 31401–31407. 28 indexed citations
18.
Tanis, Keith Q., Samuel S. Newton, & Ronald S. Duman. (2007). Targeting Neurotrophic/Growth Factor Expression and Signaling for Antidepressant Drug Development. CNS & Neurological Disorders - Drug Targets. 6(2). 151–160. 50 indexed citations
19.
Tanis, Keith Q., Ronald S. Duman, & Samuel S. Newton. (2007). CREB Binding and Activity in Brain: Regional Specificity and Induction by Electroconvulsive Seizure. Biological Psychiatry. 63(7). 710–720. 61 indexed citations
20.
Tanis, Keith Q. & Ronald S. Duman. (2007). Intracellular signaling pathways pave roads to recovery for mood disorders. Annals of Medicine. 39(7). 531–544. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026